JohnE.ErvinMDF.A.C.P., F.A.C.R.

CEO, Medical Director, and Principal Investigator at The Center for Pharmaceutical Research

Dr. Ervin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Dr. John E. Ervin earned his undergraduate degree at the University of Notre Dame and received his medical degree from the University of Kansas School of Medicine in 1976.

There he completed a Residency in Internal Medicine and a Fellowship in Allergy, Immunology, and Rheumatology. He is board-certified in both Internal Medicine and Rheumatology. In addition, Dr. Ervin has been on the teaching staff at both the University of Kansas Medical Center and the University of Missouri -- Kansas City.

John E. Ervin, M.D., F.A.C.P., F.A.C.R. founded The Center for Pharmaceutical Research in 1986, and serves as the CEO, Medical Director, and Principal Investigator. He was the first president and co-founder of The Society of Principal Investigators and is a founding member of The Alliance for Multispecialty Research. He has conducted over 800 phase I through IV clinical trials.

University of Kansas School of MedicineInternship, Internal Medicine, 1975 - 1976
University of Kansas School of MedicineResidency, Allergy and Immunology, 1974 - 1976
University of Kansas School of MedicineResidency, Internal Medicine, 1974 - 1974
University of Kansas School of MedicineClass of 1974

• “America's Top Physicians 2010" - Consumer Research Council of America
The Best Physicians in 27 Specialties, Kansas City 2003,2007,2008 BEST DOCTORS as chosen by their peers
• Fellow American College of Physicians (FACP)
• Physician Recognition Award, 2016 St. Joseph Health Center
• Patient’s Choice Award “Near Perfect Score”, Voted by Patients (Less than 5% of All Physicians in U.S.), 2008-2011
• Premier Physician Voted by Nursing Staff of St. Joseph Medical Center, 2009
• Outstanding Resident on the Medical Services, University of Kansas School of Medicine, Selected by Attending Staff,, 1975-1976
Super Doctor SuperDoctors.com
Join now to see all

PubMed

7 citations
Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial.
Dinesh Khanna, Paul Caldron, Richard W Martin, Suzanne Kafaja, Robert Spiera, Shadi Shahouri, Ankoor Shah, Vivien Hsu, John Ervin, Robert Simms, Robyn T Domsic, Virgin...> ;Arthritis & Rheumatology. 2022 Aug 1
16 citations
Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.
Geoffrey J. Gorse, Ann R. Falsey, Carol M. Johnson, Dennis Morrison, David Fried, John E. Ervin, David P. Greenberg, Ayca Ozol-Godfrey, Victoria Landolfi, Peter H. Tsang> ;Vaccine. 2013 Dec 5
20 citations
Civamide cream 0.075% in patients with osteoarthritis of the knee: a 12-week randomized controlled clinical trial with a longterm extension
Thomas J. Schnitzer, Jean-Pierre Pelletier, Doug M. Haselwood, William T. Ellison, John E. Ervin, Richard D. Gordon, Jeffrey R. Lisse, W. Tad Archambault, Allan R. Sam...> ;The Journal of Rheumatology. 2012 Mar 1

You’d Think COVID Gives Smokers a Reason to Quit. In KS and MO, Many Did the OppositeJune 14th, 2021
Inovio’s Recent Data Fails to Impress Some Analysts but Overall Data Looks Promising & Study Backed by Department of DefenseDecember 29th, 2020
Kansas City Doctor Who Oversaw Clinical Trials Stresses Importance of COVID-19 VaccineDecember 3rd, 2020
Join now to see all